Syneos Health Appoints Greg Licholai as Chief Medical Officer to Advance Next-Generation Drug Development

Further Strengthens Company's Medical Depth and Therapeutic Expertise Further Strengthens Company's Medical Depth and Therapeutic Expertise
Open original source